The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Peri-transplant supportive and palliative care and/or comorbidity management for older, medically infirm, and/or frail recipients of allogeneic hematopoietic cell transplantation (Allo-HCT): Phase II and interim phase III trial analyses.
 
Elizabeth Loggers
Research Funding - Adaptimmune (Inst); AmMax Bio (Inst); Avacta Life Sciences (Inst); Ayala Pharmaceuticals (Inst); BioAtla (Inst); Boehringer Ingelheim (Inst); Dicephera Pharmaceuticals, Inc. (Inst); Epizyme (Inst); GlaxoSmithKline (Inst); InhibRx (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); SpringWorks Therapeutics (Inst)
 
James Fausto
No Relationships to Disclose
 
Matthew Givens
No Relationships to Disclose
 
Laura Schoenherr
No Relationships to Disclose
 
Reena Jayani-Kosarzycki
No Relationships to Disclose
 
Jason Webb
Honoraria - AAHPM
Research Funding - Patient-Centered Outcomes Research Institute (PCORI) (Inst)
 
Diana Martins-Welch
No Relationships to Disclose
 
Michael Rabow
No Relationships to Disclose
 
Jeanette Ferrer
No Relationships to Disclose
 
Rachel Cook
No Relationships to Disclose
 
George Carrum
No Relationships to Disclose
 
Rebecca Olin
Honoraria - Aptitude Health (I); Axiom Healthcare Strategies (I); Clarion Healthcare (I); Equinox Group (I)
Consulting or Advisory Role - Bayer (I); Bristol-Myers Squibb/Pfizer (I); Gilead Sciences (I); Janssen Oncology (I); Rigel; SERVIER
Research Funding - AstraZeneca (Inst); Cellectis (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Roche (Inst); Spectrum Pharmaceuticals (Inst); Takeda (Inst); Verastem (Inst)
 
Laura Johnston
No Relationships to Disclose
 
Mark Juckett
No Relationships to Disclose
 
Mei-Ean Yeow
No Relationships to Disclose
 
Hassan Alkhateeb
No Relationships to Disclose
 
Ronald Sobecks
Consulting or Advisory Role - Advisory Board for CareDx, Inc.
Research Funding - Astellas Pharma; CareDx, Inc.; Marker Therapeutics, Inc; Pfizer
 
Joseph Uberti
No Relationships to Disclose
 
Mohamed Sorror
No Relationships to Disclose